Serum protein profiling by SELDI mass spectrometry: detection of multiple variants of serum amyloid alpha in renal cancer patients
- 1 July 2004
- journal article
- Published by Elsevier in Laboratory Investigation
- Vol. 84 (7) , 845-856
- https://doi.org/10.1038/labinvest.3700097
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Mass spectrometry-based proteomicsNature, 2003
- Use of proteomic patterns in serum to identify ovarian cancerPublished by Elsevier ,2002
- Recent advances in kidney cancer and metastatic diseaseBJU International, 2001
- Proteome analysis and its impact on the discovery of serological tumor markersClinica Chimica Acta; International Journal of Clinical Chemistry, 2001
- Renal cell carcinomaCurrent Opinion in Oncology, 2000
- Expression and function of serum amyloid A, a major acute-phase protein, in normal and disease statesCurrent Opinion in Hematology, 2000
- Cytokine regulation of the acute-phase protein levels in multiple myelomaEuropean Journal of Clinical Investigation, 1998
- Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal-cell carcinomaInternational Journal of Cancer, 1997
- New desorption strategies for the mass spectrometric analysis of macromoleculesRapid Communications in Mass Spectrometry, 1993
- Acute-phase protein synthesis in human hepatoma cells: differential regulation of serum amyloid A (SAA) and haptoglobin by interleukin-1 and interleukin-6Clinical and Experimental Immunology, 1991